(Q35739058)

10 August 2017

1 reference

title

Hepatocellular carcinoma: epidemic and treatment (English)

1 reference

10 August 2017

main subject

hepatocellular carcinoma

1 reference

Jill Allen

1

1 reference

10 August 2017

Alan Venook

series ordinal

2

1 reference

10 August 2017

publication date

1 May 2004

1 reference

10 August 2017

published in

Current Oncology Reports

1 reference

10 August 2017

volume

6

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

177-183

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-004-0047-9

10 August 2017

exact match

0 references

cites work

Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0047-9

Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0047-9

Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0047-9

Induction of the estrogen receptor by ablation of DNMT1 in ER-negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0047-9

Dramatic Reduction of the α-Fetoprotein Level After Lamivudine Treatment of Patients with Chronic Hepatitis B Virus Infection and Cirrhosis

21 January 2018

1 reference

12 December 2020

Hepatitis B virus infection

1 reference

12 December 2020

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

12 December 2020

Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts

1 reference

12 December 2020

Hepatitis B--an important public health issue

1 reference

12 December 2020

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial

1 reference

12 December 2020

ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, shows antimetastatic activity using a hepatocellular carcinoma model.

1 reference

12 December 2020

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

1 reference

12 December 2020

Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.

1 reference

12 December 2020

A model to predict survival in patients with end-stage liver disease

1 reference

12 December 2020

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

1 reference

12 December 2020

Review article: percutaneous treatment of hepatocellular carcinoma

1 reference

12 December 2020

Global progress toward universal childhood hepatitis B vaccination, 2003

1 reference

12 December 2020

Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomide

1 reference

12 December 2020

Epidemiology, risk factors, and natural history of hepatocellular carcinoma.

1 reference

12 December 2020

Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma

1 reference

12 December 2020

Cyclooxygenase-2 expression in hepatocellular carcinoma

1 reference

12 December 2020

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

1 reference

12 December 2020

Prospective Validation of the Cancer of the Liver Italian Program(CLIP) Score: A New Prognostic System for Patients With Cirrhosis and Hepatocellular Carcinoma

1 reference

12 December 2020

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

12 December 2020

Liver transplantation for hepatocellular carcinoma

1 reference

12 December 2020

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study

1 reference

12 December 2020

Simplified staging for hepatocellular carcinoma

1 reference

12 December 2020

Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization.

1 reference

12 December 2020

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list

1 reference

12 December 2020

Review article: natural history and prognostic prediction of patients with hepatocellular carcinoma

1 reference

12 December 2020

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma

1 reference

12 December 2020

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

12 December 2020

Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria

1 reference

12 December 2020

Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma.

1 reference

12 December 2020

Review article: liver transplantation for HCC. Treatment options on the waiting list

1 reference

12 December 2020

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

1 reference

12 December 2020

Geographic variation within the United States in the incidence of hepatocellular carcinoma

1 reference

12 December 2020

Estimating future hepatitis C morbidity, mortality, and costs in the United States

1 reference

12 December 2020

Treatment of hepatocellular carcinoma: is there an optimal strategy?

1 reference

12 December 2020

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

12 December 2020

Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma

1 reference

12 December 2020

Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?

1 reference

12 December 2020

Screening for hepatocellular carcinoma

1 reference

12 December 2020

Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation

1 reference

12 December 2020

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

12 December 2020

Epidemiology of hepatitis C

1 reference

12 December 2020

A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

1 reference

12 December 2020

Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.

1 reference

12 December 2020

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

12 December 2020

Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective

1 reference

12 December 2020

Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery

1 reference

12 December 2020

Epidemiology of hepatocellular carcinoma

1 reference

12 December 2020

The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time

1 reference

12 December 2020

Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.

1 reference

12 December 2020

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

12 December 2020

Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP)

1 reference

12 December 2020

Predictors of postoperative diffuse intrahepatic recurrence of hepatocellular carcinoma

1 reference

12 December 2020

Review article: hepatocellular carcinoma: indications for liver transplantation

1 reference

12 December 2020

10.1007/S11912-004-0047-9

Identifiers

DOI

1 reference

10 August 2017

1 reference